Does IMIPENEM Cause Bronchopulmonary aspergillosis? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Bronchopulmonary aspergillosis have been filed in association with IMIPENEM. This represents 1.2% of all adverse event reports for IMIPENEM.
23
Reports of Bronchopulmonary aspergillosis with IMIPENEM
1.2%
of all IMIPENEM reports
15
Deaths
22
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From IMIPENEM?
Of the 23 reports, 15 (65.2%) resulted in death, 22 (95.7%) required hospitalization, and 9 (39.1%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMIPENEM. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does IMIPENEM Cause?
Drug ineffective (351)
Off label use (202)
Condition aggravated (138)
Vomiting (137)
Drug resistance (117)
Nausea (111)
Dyspnoea (97)
Diarrhoea (90)
Pyrexia (90)
Product use in unapproved indication (85)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
Which IMIPENEM Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
IMIPENEM vs IMIPRAMINE
IMIPENEM vs IMIQUIMOD
IMIPENEM vs IMITREX
IMIPENEM vs IMMUNE GLOBULIN NOS
IMIPENEM vs IMPLANON